These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2079647)

  • 1. Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum.
    Hashimoto K; Suzuki I; Ohsawa M; Oikawa S; Yadomae T
    J Pharmacobiodyn; 1990 Aug; 13(8):512-7. PubMed ID: 2079647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
    Sakurai T; Suzuki I; Kinoshita A; Oikawa S; Masuda A; Ohsawa M; Yadomae T
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):214-7. PubMed ID: 2049804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M; Ohno N; Adachi Y; Yadomae T
    J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T; Kaise T; Yadomae T; Matsubara C
    Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
    Sakurai T; Ohno N; Yadomae T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2120-4. PubMed ID: 1423766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
    Sakurai T; Ohno N; Suzuki I; Yadomae T
    Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N; Kurachi K; Yadomae T
    J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells.
    Hashimoto K; Suzuki I; Yadomae T
    Int J Immunopharmacol; 1991; 13(4):437-42. PubMed ID: 1828793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
    Suzuki I; Hashimoto K; Yadomae T
    J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
    Kurachi K; Ohno N; Yadomae T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by orally administered beta-glucan in mice.
    Suzuki I; Hashimoto K; Ohno N; Tanaka H; Yadomae T
    Int J Immunopharmacol; 1989; 11(7):761-9. PubMed ID: 2599714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of murine alveolar macrophage functions by orally administered beta-glucan.
    Sakurai T; Hashimoto K; Suzuki I; Ohno N; Oikawa S; Masuda A; Yadomae T
    Int J Immunopharmacol; 1992 Jul; 14(5):821-30. PubMed ID: 1512075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in immune mediators in mouse lung produced by administration of soluble (1-->3)-beta-D-glucan.
    Sakurai T; Ohno N; Yadomae T
    Biol Pharm Bull; 1994 May; 17(5):617-22. PubMed ID: 7920419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.
    Ohno N; Asada N; Adachi Y; Yadomae T
    Biol Pharm Bull; 1995 Jan; 18(1):126-33. PubMed ID: 7735226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemopoietic effects of intravenous soluble glucan administration.
    Patchen ML; MacVittie TJ
    J Immunopharmacol; 1986; 8(3):407-25. PubMed ID: 3760593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of orally administered beta-glucan on macrophage function in mice.
    Suzuki I; Tanaka H; Kinoshita A; Oikawa S; Osawa M; Yadomae T
    Int J Immunopharmacol; 1990; 12(6):675-84. PubMed ID: 2272730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases in hematopoietic responses caused by beta-glucans in mice.
    Tateishi T; Ohno N; Adachi Y; Yadomae T
    Biosci Biotechnol Biochem; 1997 Sep; 61(9):1548-53. PubMed ID: 9339557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Biol Pharm Bull; 1994 Jan; 17(1):131-5. PubMed ID: 8148801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.